Temporal development of T cell receptor repertoires during childhood in health and disease.
Adaptive immunity
Autoimmunity
Diabetes
Immunology
T cell receptor
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
22 09 2022
22 09 2022
Historique:
received:
16
05
2022
accepted:
17
08
2022
pubmed:
24
8
2022
medline:
24
9
2022
entrez:
23
8
2022
Statut:
epublish
Résumé
T cell receptor (TCR) sequences are exceptionally diverse and can now be comprehensively measured with next-generation sequencing technologies. However, a thorough investigation of longitudinal TCR repertoires throughout childhood in health and during development of a common childhood disease, type 1 diabetes (T1D), has not been undertaken. Here, we deep sequenced the TCR-β chain repertoires from longitudinal peripheral blood DNA samples at 4 time points beginning early in life (median age of 1.4 years) from children who progressed to T1D (n = 29) and age/sex-matched islet autoantibody-negative controls (n = 25). From 53 million TCR-β sequences, we show that the repertoire is extraordinarily diverse early in life and narrows with age independently of disease. We demonstrate the ability to identify specific TCR sequences, including those known to recognize influenza A and, separately, those specific for insulin and its precursor, preproinsulin. Insulin-reactive TCR-β sequences were more common and frequent in number as the disease progressed in those who developed T1D compared with genetically at risk nondiabetic children, and this was not the case for influenza-reactive sequences. As an independent validation, we sequenced and analyzed TCR-β repertoires from a cohort of new-onset T1D patients (n = 143), identifying the same preproinsulin-reactive TCRs. These results demonstrate an enrichment of preproinsulin-reactive TCR sequences during the progression to T1D, highlighting the importance of using disease-relevant TCR sequences as powerful biomarkers in autoimmune disorders.
Identifiants
pubmed: 35998036
pii: 161885
doi: 10.1172/jci.insight.161885
pmc: PMC9675557
doi:
pii:
Substances chimiques
Receptors, Antigen, T-Cell
0
Receptors, Antigen, T-Cell, alpha-beta
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : DP3 DK110845
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099317
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002535
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK032493
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK116073
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK032083
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56 DK099317
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK032493
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK032083
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK108868
Pays : United States
Références
JAMA. 2013 Jun 19;309(23):2473-9
pubmed: 23780460
Science. 2016 Feb 12;351(6274):711-4
pubmed: 26912858
J Immunol. 2011 Apr 1;186(7):4285-94
pubmed: 21383244
Clin Transl Immunology. 2021 Jul 26;10(7):e1315
pubmed: 34336205
Nat Biotechnol. 2020 Oct;38(10):1194-1202
pubmed: 32341563
Genome Res. 2009 Oct;19(10):1817-24
pubmed: 19541912
J Clin Invest. 2018 May 1;128(5):1888-1902
pubmed: 29438107
Immunity. 2020 Aug 18;53(2):442-455.e4
pubmed: 32668194
Proc Natl Acad Sci U S A. 2021 Oct 12;118(41):
pubmed: 34611019
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4429-34
pubmed: 25831495
Front Endocrinol (Lausanne). 2021 Mar 25;12:622647
pubmed: 33841327
Sci Transl Med. 2010 Sep 1;2(47):47ra64
pubmed: 20811043
Sci Adv. 2019 Aug 21;5(8):eaaw9336
pubmed: 31457096
Diabetes. 2015 Jan;64(1):172-82
pubmed: 25157096
J Immunol. 2014 Mar 15;192(6):2689-98
pubmed: 24510963
Diabetes. 2017 Mar;66(3):722-734
pubmed: 27920090
Sci Transl Med. 2021 Mar 31;13(587):
pubmed: 33790023
J Immunol. 2016 Jun 15;196(12):5005-13
pubmed: 27183615
Annu Rev Immunol. 2015;33:169-200
pubmed: 25493333
Lancet. 2014 Jan 4;383(9911):69-82
pubmed: 23890997
Nat Med. 2016 Dec;22(12):1482-1487
pubmed: 27798614
Blood. 2009 Nov 5;114(19):4099-107
pubmed: 19706884
Diabetologia. 2016 Nov;59(11):2448-2458
pubmed: 27506584
J Clin Endocrinol Metab. 1996 Dec;81(12):4264-7
pubmed: 8954025
J Exp Med. 2012 Jan 16;209(1):51-60
pubmed: 22213807
Cell Res. 2012 Jan;22(1):33-42
pubmed: 22212481
BMC Immunol. 2019 Jun 21;20(1):19
pubmed: 31226930
Nature. 2017 Jul 6;547(7661):94-98
pubmed: 28636589
Nat Commun. 2013;4:2680
pubmed: 24157944
Nat Immunol. 2001 Jun;2(6):501-7
pubmed: 11376336
Nat Rev Immunol. 2008 Mar;8(3):231-8
pubmed: 18301425
Ann N Y Acad Sci. 2003 Nov;1005:301-9
pubmed: 14679080
Adv Immunol. 2013;119:1-50
pubmed: 23886063
J Autoimmun. 2021 Feb;117:102574
pubmed: 33307312
J Exp Med. 2002 Mar 4;195(5):571-81
pubmed: 11877480
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):162-167
pubmed: 29255035
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14840-5
pubmed: 25267644
Diabetologia. 1996 Jul;39(7):807-12
pubmed: 8817105
J Clin Invest. 2001 Jan;107(2):173-80
pubmed: 11160133
J Life Sci (Westlake Village). 2020 Dec;2(4):38-58
pubmed: 33364626
Bioinformatics. 2004 Aug 4;20 Suppl 1:i379-85
pubmed: 15262823
Nature. 2010 Apr 29;464(7293):1293-300
pubmed: 20432533
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5
pubmed: 17942684
Diabetes. 2016 Mar;65(3):719-31
pubmed: 26581594
Mol Oncol. 2015 Dec;9(10):2063-70
pubmed: 26404496
Diabetes Care. 2015 Oct;38(10):1964-74
pubmed: 26404926
Sci Transl Med. 2017 Feb 22;9(378):
pubmed: 28228602